======= TXLNG ======= == Gene Information == * **Official Symbol**: TXLNG * **Official Name**: taxilin gamma * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55787|55787]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NUQ3|Q9NUQ3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TXLNG&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TXLNG|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300677|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the taxilin family. The encoded protein binds to the C-terminal coiled-coil region of syntaxin family members 1A, 3A and 4A, and may play a role in intracellular vesicle trafficking. This gene is up-regulated by lipopolysaccharide and the gene product may be involved in cell cycle regulation. The related mouse protein was also shown to inhibit activating transcription factor 4-mediated transcription and thus regulate bone mass accrual. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]. * **UniProt Summary**: May be involved in intracellular vesicle traffic. Inhibits ATF4-mediated transcription, possibly by dimerizing with ATF4 to form inactive dimers that cannot bind DNA. May be involved in regulating bone mass density through an ATF4-dependent pathway. May be involved in cell cycle progression. {ECO:0000269|PubMed:15911876, ECO:0000269|PubMed:18068885}. |Taxilin| |syntaxin binding| |regulation of bone mineralization| |regulation of biomineral tissue development| |regulation of biomineralization| |regulation of ossification| |nuclear membrane| |protein heterodimerization activity| |regulation of cell cycle process| |regulation of cell cycle| |cell cycle| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp481|Ethambutol 25μM R08 exp481]]|-1.82| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-1.81| |[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|-1.77| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.76| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.73| |[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|-1.72| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.82| |[[:results:exp144|PFI-3 10μM R03 exp144]]|2.01| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|2.14| |[[:results:exp516|Pyrazinamide 100μM R08 exp516]]|2.46| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10014 * **Expression level (log2 read counts)**: 6.23 {{:chemogenomics:nalm6 dist.png?nolink |}}